Microbicide for prevention of sexually transmitted diseases using a pharmaceutical excipient

A R Neurath1

  • 1New York Blood Center, NY, USA. rneurath@nybc.org

Insights

Cellulose acetate phthalate, a polymer used in tablet coatings, effectively inactivates sexually transmitted pathogens like HIV-1. This compound is safe, inexpensive, and widely available, making it a promising microbicide candidate.

Area of Science:

  • Microbiology
  • Public Health
  • Polymer Science

Background:

  • Microbicides are crucial for preventing sexually transmitted diseases (STDs).
  • Ideal microbicides must target pathogens without harming beneficial vaginal lactobacilli.
  • Existing microbicides face challenges with availability, cost, and safety.

Purpose of the Study:

  • To evaluate cellulose acetate phthalate (C-A-P) as a potential microbicide.
  • To determine if C-A-P meets the criteria for an effective and safe microbicide.

Main Methods:

  • Assessing C-A-P's efficacy against various sexually transmitted viral and nonviral pathogens.
  • Evaluating C-A-P's impact on lactobacilli populations.
  • Considering C-A-P's availability, cost, and established safety profile.

Main Results:

  • Cellulose acetate phthalate demonstrated inactivation of key STD pathogens, including HIV-1.
  • C-A-P did not adversely affect lactobacilli, preserving the natural vaginal defense system.
  • The compound is widely available, inexpensive, and possesses a known human safety record.

Conclusions:

  • Cellulose acetate phthalate meets all essential criteria for a preferred microbicide.
  • C-A-P represents a promising, accessible, and safe option for STD prevention.

Related Concept Videos

Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Transdermal Drug Delivery Systems01:18

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...